These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7621482)

  • 21. Cerebral blood flow and cerebrovascular reserve 5 years after EC-IC bypass.
    Holzschuh M; Brawanski A; Ullrich W; Meixensberger J
    Neurosurg Rev; 1991; 14(4):275-8. PubMed ID: 1791941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xe-CT in cerebrovascular disease and moyamoya disease.
    Suzuki R; Nariai T; Matsushima Y; Hirakawa K
    Acta Neurol Scand Suppl; 1996; 166():69-71. PubMed ID: 8686446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic stress distribution reflects ischemic clinical symptoms of patients with moyamoya disease.
    Takahashi S; Tanizaki Y; Kimura H; Akaji K; Nakazawa M; Yoshida K; Mihara B
    Clin Neurol Neurosurg; 2015 Nov; 138():104-10. PubMed ID: 26318361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease.
    Touho H; Karasawa J; Ohnishi H
    Stroke; 1996 Feb; 27(2):282-9. PubMed ID: 8571424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT.
    Yamamoto S; Watanabe M; Uematsu T; Takasawa K; Nukata M; Kinoshita N
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):242-7. PubMed ID: 14970024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral blood flow in children with spontaneous occlusion of the circle of Willis (moyamoya disease): comparison with healthy children and evaluation of annual changes.
    Kuroda S; Kamiyama H; Abe H; Yamauchi T; Kohama Y; Houkin K; Mitsumori K
    Neurol Med Chir (Tokyo); 1993 Jul; 33(7):434-8. PubMed ID: 7692320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arteriovenous malformation associated with moyamoya disease.
    Fuse T; Takagi T; Fukushima T; Hashimoto N; Yamada K
    Childs Nerv Syst; 1996 Jul; 12(7):404-8. PubMed ID: 8869778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral blood flow and cerebrovascular reactivity capacity in patients with bilateral high-grade carotid artery stenosis.
    Liu HM; Tu YK; Yip PK; Su CT
    Acta Neurol Scand Suppl; 1996; 166():90-2. PubMed ID: 8686451
    [No Abstract]   [Full Text] [Related]  

  • 30. Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.
    Li Z; Zhou P; Xiong Z; Ma Z; Wang S; Bian H; Chen J
    Cerebrovasc Dis; 2013; 35(5):455-60. PubMed ID: 23735877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemodynamic ischaemia in paediatric moyamoya disease associated with renovascular hypertension.
    Takagi Y; Hashimoto N; Goto Y
    Acta Neurochir (Wien); 1997; 139(3):257-8. PubMed ID: 9143594
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgical treatment of moyamoya disease in pediatric age.
    Caldarelli M; Di Rocco C; Gaglini P
    J Neurosurg Sci; 2001 Jun; 45(2):83-91. PubMed ID: 11533532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative assessment of cortical perfusion by indocyanine green videoangiography in surgical revascularization for moyamoya disease.
    Uchino H; Kazumata K; Ito M; Nakayama N; Kuroda S; Houkin K
    Acta Neurochir (Wien); 2014 Sep; 156(9):1753-60. PubMed ID: 24973201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid and near-complete resolution of moyamoya vessels in a patient with moyamoya disease treated with superficial temporal artery-middle cerebral artery bypass.
    Wang MY; Steinberg GK
    Pediatr Neurosurg; 1996; 24(3):145-50. PubMed ID: 8870018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dramatic disappearance of moyamoya disease-induced chorea after indirect bypass surgery.
    Kamijo K; Matsui T
    Neurol Med Chir (Tokyo); 2008 Sep; 48(9):390-3. PubMed ID: 18812680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
    Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
    World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
    Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involuntary movement induced by cerebral ischemia: pathogenesis and surgical outcome.
    Im SH; Oh CW; Kwon OK; Cho BK; Chung YS; Han DH
    J Neurosurg; 2004 May; 100(5):877-82. PubMed ID: 15137607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristic EEG findings in childhood moyamoya syndrome.
    Kurlemann G; Fahrendorf G; Krings W; Sciuk J; Palm D
    Neurosurg Rev; 1992; 15(1):57-60. PubMed ID: 1584439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bifrontal encephalogaleosynangiosis for children with moyamoya disease.
    Ogiwara H; Morota N
    J Neurosurg Pediatr; 2012 Sep; 10(3):246-51. PubMed ID: 22816605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.